Characterisation of methicillin-resistant Staphylococcus aureus from Kuwait hospitals with high-level fusidic acid resistance

Journal of Medical Microbiology

Volumn 49, Issue 5, 2000, Pages 419-426

  Udo, E E ^a   Jacob, L E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM ACETATE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; FUSIDIC ACID; GENTAMICIN; HEMOLYSIN; KANAMYCIN; METICILLIN; MINOCYCLINE; NEOMYCIN; PENICILLIN G; PHOSPHOLIPASE; PIGMENT; PROPAMIDINE ISETHIONATE; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TRIACYLGLYCEROL LIPASE; TRIMETHOPRIM; UREASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOTYPOLOGY; CHROMOSOME; CLONE; CONTROLLED STUDY; ENZYME SYNTHESIS; GENETIC ANALYSIS; HOSPITAL; HUMAN; INFECTION CONTROL; KUWAIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE;

STAPHYLOCOCCUS AUREUS;

EID: 0034019754     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-5-419     Document Type: Article

References (30)

1. 1. Verbist L. The antimicrobial activity of fusidic acid. J Antimicrob Chemother 1990; 25 Suppl B: 1-5.
2. 2. Lambert HP, O'Grady FW. Antibiotic and chemotherapy, 6th edn. London, Churchill Livingstone 1992: 157-159.
3. 3. Portier H. A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections. J Antimicrob Chemother 1990; 25 Suppl B: 39-44.
4. 4. Huebner J, Kropec A, Engels I, Daschner F. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime producing coagulase-negative staphylococci to fusidic acid. Chemotherapy 1992; 38: 206-210.
5. 5. Drugeon HB, Caillon J, Juvin ME. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus. J Antimicrob Chemother 1994; 34: 899-907.
6. 6. Coombs RRH. Fusidic acid in Staphylococcal bone and joint infection. J Antimicrob Chemother 1990; 25 Suppl B: 53-60.
7. 7. Eykyn SJ. Staphylococcal bacteraemia and endocarditis and fusidic acid. J Antimicrob Chemother 1990; 25 Suppl B: 33-38.
8. 8. Chopra I. Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol 1976; 96: 229-238.
9. 9. O'Brien FG, Botterill CI, Endersby TG, Lim RLG, Grubb WB, Gustafson JE. Heterogeneous expression of fusidic acid resistance in Staphylococcus aureus with plasmid or chromosomally encoded fusidic acid resistance genes. Pathology 1998; 30: 299-303.
10. 10. Lacey RW, Rosdahl VT. An unusual 'penicillinase plasmid' in Staphylococcus aureus: evidence for its transfer under natural conditions. J Med Microbiol 1974; 7: 1-9.
11. 11. Lacey RW, Grinsted J. Linkage of fusidic acid resistance to the pencillinase plasmid in Staphylococcus aureus. J Gen Microbiol 1972; 73: 501-508.
12. 12. Courvalin P, Fiandt M. Aminoglycoside-modifying enzymes of Staphylococcus aureus; expression in Esherichia coli. Gene 1980; 9: 247-269.
13. 13. Sinden D, Chopra I. Fusidic acid resistance in Staphylococcus aureus. Zentalbl Bakteriol 1981; Suppl 10: 571-574.
14. 14. Faber M, Rosdahl VT. Susceptibility of fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption. J Antimicob Chemother 1990; 25 Suppl B: 7-14.
15. 15. Toma E, Barriault D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol 1995; 33: 1712-1715.
16. 16. Shanson DC. Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J Antimicrob Chemother 1990; 25 Suppl B: 15-21.
17. 17. Gransden WR, Eykyn SJ, Phillips I. Staphylococcus aureus bacteraemia: 400 episodes in St. Thomas's Hospital. BMJ 1984; 288: 300-303.
18. 18. Turnidge J, Lawson P, Munro R, Benn R. A national survey of antimicrobial resistance in Staphylococcus aureus in Australian hospitals. Med J Aust 1989; 150: 65-72.
19. 19. Turnidge JD, Nimmo GR, Francis G. Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Med J Aust 1996; 164: 68-71.
20. 20. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust 1995; 163: 412-414.
21. 21. Zaman R, Dibb WL. Methicillin-resistant Staphylococcus aureus (MRSA) isolated in Saudi Arabia: epidemiology and antimicrobial resistance patterns. J Hosp Infect 1994; 26: 297-300.
22. 22. Torvaldsen S, Riley T. Emerging sodium fusidate resistance in Western Australian methicillin-resistant Staphylococcus aureus. Comm Dis Intel 1996; 20: 492-494.
23. 23. Lang S, Raymond N, Brett M. Mupirocin-resistant S. aureus in Auckland. N Z Med J 1992; 105: 438.
24. 24. Struelens MJ. Tracking the epidemiology of antimicrobial drug resistance in hospitals: time to deploy molecular typing. J Med Microbiol 1998; 47: 1035-1036.
25. 25. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Wayne, PA, NCCLS. 1998.
26. 26. A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 1991; 27 Suppl D: 1-50.
27. 27. Hamilton-Miller JMT, Maple PAC. Antibiogram typing of methicillin-resistant Staphylococcus aureus: a comparison with phage typing, biotyping and API Staph. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 279: 214-224.
28. 28. Townsend DE, Ashdown N, Bolton S, Grubb WB. The use of cetyltrimethylammonium bromide for the rapid isolation from Staphylococcus aureus of relaxable and non-relaxable plasmid DNA suitable for in vitro manipulation. Lett Appl Microbiol 1985; 1: 87-94.
29. 29. Udo EE, Grubb WB. Genetic analysis of methicillin-resistant Staphylococcus aureus from a Nigerian hospital. J Med Microbiol 1993; 38: 203-208.
30. 30. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.